Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Brain Neoplasms 405Glioma 261Glioblastoma 204Central Nervous System Neoplasms 92Neoplasms 87Neuroblastoma 82Astrocytoma 72Neurofibromatosis 1 55Breast Neoplasms 52Meningioma 51Lung Neoplasms 42Oligodendroglioma 39Head and Neck Neoplasms 35Medulloblastoma 33Spinal Cord Neoplasms 30Sarcoma 30Leukemia 30Paraganglioma 29Pheochromocytoma 28Lymphoma 28Carcinoma, Non-Small-Cell Lung 27Prostatic Neoplasms 24Neuroma, Acoustic 24Ependymoma 24Melanoma 22Recurrence 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Ovarian Neoplasms 20Neoplasm Metastasis 19Lymphoma, Non-Hodgkin 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neurodevelopmental Disorders × CNS × Clear all
NCT06251830 2024-02-09

Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?

IRCCS Fondazione Stella Maris

Completed
610 enrolled
CNS

Brain Neoplasms, Epilepsy, Multiple Sclerosis, Neurodegenerative Diseases, Neurodevelopmental Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡